A Phase 2 Study of KZR-616 to Evaluate Safety and Efficacy in Patients With Active Polymyositis or Dermatomyositis
Clinical trial NCT04033926 · COMPLETED
Trial details
- NCT number
- NCT04033926
- Sponsor
- Kezar Life Sciences, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-14
- Primary completion
- 2022-04-06
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.